PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
von Berg, A.* ; Filipiak-Pittroff, B.* ; Schulz, H. ; Hoffmann, U. ; Link, E.* ; Sußmann, M. ; Schnappinger, M. ; Brüske, I. ; Standl, M. ; Krämer, U.* ; Hoffmann, B.* ; Heinrich, J. ; Bauer, C.P.* ; Koletzko, S.* ; Berdel, D.* ; GINIplus Study Group (*)

Allergic manifestation 15 years after early intervention with hydrolyzed formulas - the GINI study.

Allergy 71, 210-219 (2016)
Publ. Version/Full Text DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: Data on the long-term impact of hydrolyzed formulas on allergies are scarce. OBJECTIVE: To assess the association between early intervention with hydrolyzed formulas in high-risk children and allergic outcomes in adolescence. METHODS: GINI trial participants (N=2252) received one of four formulas in the first four months of life as breastmilk substitute if necessary: partial or extensive whey hydrolyzate (pHF-W, eHF-W), extensive casein hydrolyzate (eHF-C) or standard cow's milk formula (CMF) as reference. Associations between these formulas and the cumulative incidence and prevalence of parent reported physician-diagnosed asthma, allergic rhinitis (AR) and eczema, as well as spirometric indices and sensitization, were examined using generalized linear models. RESULTS: Between 11 and 15 years, the prevalence of asthma was reduced in the eHF-C group compared to CMF (odds ratio (OR) 0.49, 95% confidence interval (CI) 0.26-0.89), which is consistent with the spirometric results. The cumulative incidence of AR was lower in eHF-C (Risk Ratio (RR) 0.77, 95% CI 0.59-0.99]) and the AR prevalence in pHF-W (OR 0.67, 95% CI 0.47-0.95) and eHF-C (OR 0.59, 95% CI 0.41-0.84). The cumulative incidence of eczema was reduced in pHF-W (RR 0.75, 95% CI 0.59-0.96) and eHF-C (RR 0.60, 95% CI 0.46-0.77), as was the eczema prevalence between 11 and 15 years in eHF-C (OR 0.42, 95% CI 0.23-0.79). No significant effects were found in the eHF-W group or for sensitization. CONCLUSION: In high-risk children, early intervention using different hydrolyzed formulas has variable preventative effects on asthma, allergic rhinitis and eczema up to adolescence.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.335
1.882
61
81
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords 15-year Follow-up From Birth ; Allergy Prevention ; Double-blind ; Hydrolyzed Infant Formulas ; Nutritional Intervention ; Randomized Trial; Infant Nutritional Intervention; Primary Prevention; Dietary Prevention; Disease; Children; Asthma; Age; Recommendations; Avoidance; Childhood
Language english
Publication Year 2016
Prepublished in Year 2015
HGF-reported in Year 2015
ISSN (print) / ISBN 0105-4538
e-ISSN 1398-9995
Journal Allergy
Quellenangaben Volume: 71, Issue: 2, Pages: 210-219 Article Number: , Supplement: ,
Publisher Wiley
Publishing Place Hoboken
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology (EPI)
POF-Topic(s) 30503 - Chronic Diseases of the Lung and Allergies
80000 - German Center for Lung Research
Research field(s) Genetics and Epidemiology
PSP Element(s) G-503900-003
G-503900-001
G-501800-391
PubMed ID 26465137
DOI 10.1111/all.12790
WOS ID WOS:000368853700008
Scopus ID 84955385951
Scopus ID 84947975767
Erfassungsdatum 2015-12-02
[➜Report correction]